These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12605492)

  • 1. Selective inhibition of engineered receptors via proximity-accelerated alkylation.
    Levitsky K; Ciolli CJ; Belshaw PJ
    Org Lett; 2003 Mar; 5(5):693-6. PubMed ID: 12605492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent labelling of fusion proteins in live cells via an engineered receptor-ligand pair.
    Krusemark CJ; Belshaw PJ
    Org Biomol Chem; 2007 Jul; 5(14):2201-4. PubMed ID: 17609747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorescence polarization-based assay for peptidyl prolyl cis/trans isomerase cyclophilin A.
    Liu Y; Jiang J; Richardson PL; Reddy RD; Johnson DD; Kati WM
    Anal Biochem; 2006 Sep; 356(1):100-7. PubMed ID: 16737676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity.
    Hong F; Lee J; Piao YJ; Jae YK; Kim YJ; Oh C; Seo JS; Yun YS; Yang CW; Ha J; Kim SS
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1073-80. PubMed ID: 15044094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exo-mechanism proximity-accelerated alkylations: investigations of linkers, electrophiles and surface mutations in engineered cyclophilin-cyclosporin systems.
    Levitsky K; Boersma MD; Ciolli CJ; Belshaw PJ
    Chembiochem; 2005 May; 6(5):890-9. PubMed ID: 15832403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidyl-prolyl isomerase inhibitors.
    Wang XJ; Etzkorn FA
    Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization and refolding in vitro of a recombinant human cyclophilin A mutant: effect of a single Pro/Ser substitution on cyclophilin A structure and properties.
    Xu LR; Yan X; Luo M; Guan YX; Yao SJ
    Biotechnol Prog; 2008; 24(2):302-10. PubMed ID: 18333624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical tagging of a drug target using 5-sulfonyl tetrazole.
    Otsuki S; Nishimura S; Takabatake H; Nakajima K; Takasu Y; Yagura T; Sakai Y; Hattori A; Kakeya H
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1608-11. PubMed ID: 23414805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermodynamics of buried water clusters at a protein-ligand binding interface.
    Li Z; Lazaridis T
    J Phys Chem B; 2006 Jan; 110(3):1464-75. PubMed ID: 16471698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the complex of brugia malayi cyclophilin and cyclosporin A.
    Ellis PJ; Carlow CK; Ma D; Kuhn P
    Biochemistry; 2000 Jan; 39(3):592-8. PubMed ID: 10642184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling studies in the complex between cyclophilin and cyclosporin A.
    Gallion S; Ringe D
    Protein Eng; 1992 Jul; 5(5):391-7. PubMed ID: 1518786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of recombinant ligand-binding domains from the ecdysone receptors of four pest insects.
    Graham LD; Pilling PA; Eaton RE; Gorman JJ; Braybrook C; Hannan GN; Pawlak-Skrzecz A; Noyce L; Lovrecz GO; Lu L; Hill RJ
    Protein Expr Purif; 2007 Jun; 53(2):309-24. PubMed ID: 17275327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the leukemia inhibitory factor receptor functional domains by chimeric receptors and cytokines.
    Aasland D; Schuster B; Grötzinger J; Rose-John S; Kallen KJ
    Biochemistry; 2003 May; 42(18):5244-52. PubMed ID: 12731865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation kinetics of a binary complex in solution by protein displacement.
    Launay H; Parent B; Page A; Hanoulle X; Lippens G
    Angew Chem Int Ed Engl; 2013 Nov; 52(48):12587-91. PubMed ID: 24123878
    [No Abstract]   [Full Text] [Related]  

  • 15. Thermodynamic analysis of cyclosporin a binding to cyclophilin a in a lung tumor tissue lysate.
    Wang MZ; Shetty JT; Howard BA; Campa MJ; Patz EF; Fitzgerald MC
    Anal Chem; 2004 Aug; 76(15):4343-8. PubMed ID: 15283571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic and structural characterization of non-peptide ligand-cyclophilin complexes.
    Kontopidis G; Taylor P; Walkinshaw MD
    Acta Crystallogr D Biol Crystallogr; 2004 Mar; 60(Pt 3):479-85. PubMed ID: 14993672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability engineering, biophysical, and biological characterization of the myeloid activating receptor immunoglobulin-like transcript 1 (ILT1/LIR-7/LILRA2).
    Chen Y; Chu F; Gao F; Zhou B; Gao GF
    Protein Expr Purif; 2007 Dec; 56(2):253-60. PubMed ID: 17920929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling correlated main-chain motions in proteins for flexible molecular recognition.
    Zavodszky MI; Lei M; Thorpe MF; Day AR; Kuhn LA
    Proteins; 2004 Nov; 57(2):243-61. PubMed ID: 15340912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and peptidyl-prolyl isomerase inhibitory activity of quinoxalines as ligands of cyclophilin A.
    Wang F; Chen J; Liu X; Shen X; He X; Jiang H; Bai D
    Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):372-6. PubMed ID: 16508195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand binding to the human MT2 melatonin receptor: the role of residues in transmembrane domains 3, 6, and 7.
    Mazna P; Berka K; Jelinkova I; Balik A; Svoboda P; Obsilova V; Obsil T; Teisinger J
    Biochem Biophys Res Commun; 2005 Jul; 332(3):726-34. PubMed ID: 15913560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.